BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10660616)

  • 1. Stable expression of a dominant negative mutant of CCAAT binding factor/NF-Y in mouse fibroblast cells resulting in retardation of cell growth and inhibition of transcription of various cellular genes.
    Hu Q; Maity SN
    J Biol Chem; 2000 Feb; 275(6):4435-44. PubMed ID: 10660616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C/EBPalpha inhibits cell growth via direct repression of E2F-DP-mediated transcription.
    Slomiany BA; D'Arigo KL; Kelly MM; Kurtz DT
    Mol Cell Biol; 2000 Aug; 20(16):5986-97. PubMed ID: 10913181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.
    Bargou RC; Wagener C; Bommert K; Arnold W; Daniel PT; Mapara MY; Grinstein E; Royer HD; Dörken B
    J Exp Med; 1996 Mar; 183(3):1205-13. PubMed ID: 8642262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive and negative regulation of the human thymidine kinase promoter mediated by CCAAT binding transcription factors NF-Y/CBF, dbpA, and CDP/cut.
    Kim EC; Lau JS; Rawlings S; Lee AS
    Cell Growth Differ; 1997 Dec; 8(12):1329-38. PubMed ID: 9419421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCAAT binding factor (CBF) binding mediates cell cycle activation of topoisomerase IIalpha. Conventional CBF activation domains are not required.
    Hu Q; Bhattacharya C; Maity SN
    J Biol Chem; 2002 Oct; 277(40):37191-200. PubMed ID: 12149265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions.
    Wang W; Dong L; Saville B; Safe S
    Mol Endocrinol; 1999 Aug; 13(8):1373-87. PubMed ID: 10446910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wilms' tumor suppressor gene (wt1) product represses different functional classes of transcriptional activation domains.
    Lee TH; Moffett P; Pelletier J
    Nucleic Acids Res; 1999 Jul; 27(14):2889-97. PubMed ID: 10390530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 regulates caveolin gene transcription, cell cholesterol, and growth by a novel mechanism.
    Bist A; Fielding CJ; Fielding PE
    Biochemistry; 2000 Feb; 39(8):1966-72. PubMed ID: 10684646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation of the human cdc2 promoter by adenovirus E1A. E1A induces the expression and assembly of a heteromeric complex consisting of the CCAAT box binding factor, CBF/NF-Y, and a 110-kDa DNA-binding protein.
    Kao CY; Tanimoto A; Arima N; Sasaguri Y; Padmanabhan R
    J Biol Chem; 1999 Aug; 274(33):23043-51. PubMed ID: 10438472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
    Hsiao KM; McMahon SL; Farnham PJ
    Genes Dev; 1994 Jul; 8(13):1526-37. PubMed ID: 7958837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of transcription factor E2F1 induces quiescent cells to enter S phase.
    Johnson DG; Schwarz JK; Cress WD; Nevins JR
    Nature; 1993 Sep; 365(6444):349-52. PubMed ID: 8377827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.
    Ohtani K; Iwanaga R; Nakamura M; Ikeda M; Yabuta N; Tsuruga H; Nojima H
    Oncogene; 1999 Apr; 18(14):2299-309. PubMed ID: 10327050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rous sarcoma virus enhancer factor I is a ubiquitous CCAAT transcription factor highly related to CBF and NF-Y.
    Faber M; Sealy L
    J Biol Chem; 1990 Dec; 265(36):22243-54. PubMed ID: 2176209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional roles of E2F in cell cycle regulation.
    Fan J; Bertino JR
    Oncogene; 1997 Mar; 14(10):1191-200. PubMed ID: 9121768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F-mediated growth regulation requires transcription factor cooperation.
    van Ginkel PR; Hsiao KM; Schjerven H; Farnham PJ
    J Biol Chem; 1997 Jul; 272(29):18367-74. PubMed ID: 9218478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription.
    Kundu M; Guermah M; Roeder RG; Amini S; Khalili K
    J Biol Chem; 1997 Nov; 272(47):29468-74. PubMed ID: 9368006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdk2-dependent and -independent pathways in E2F-mediated S phase induction.
    Arata Y; Fujita M; Ohtani K; Kijima S; Kato JY
    J Biol Chem; 2000 Mar; 275(9):6337-45. PubMed ID: 10692433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.